Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enolization method for 16 beta-methyl steroids offers high yield and stable reaction. Reduces steps and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN114835689B details a solvent-free route for Irbesartan enhancing purity and reducing processing steps for global supply chain efficiency.
Patent CN1910140A details a high-yield route for ZD6126 phenol via acid-catalyzed oxidation, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN101891797B reveals a selective hydrolysis method for 17α-esters, offering high purity and yield for reliable steroid intermediate supply chains.
Advanced two-stage hydrogenation patent CN1312109C enables high-purity xylylenediamine production with reduced impurities and optimized supply chain efficiency for global chemical manufacturers.
Patent CN112500361A reveals a green synthesis route for (S)-4-phenyl-2-oxazolidinone, replacing toxic reagents with safe borane reduction for cost-effective manufacturing.
Patent CN119462437A reveals high-purity trifluoroethyl triflate synthesis. Enables cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing.
Novel copper catalyzed route for amidine intermediates offers cost effective scalable high purity production for global pharmaceutical supply chains and manufacturing.
Patent CN119751419B reveals efficient palladium-catalyzed indole synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112266381B details a cost-effective synthesis of Barosavir intermediates using early resolution, offering significant supply chain advantages for API manufacturers.
Novel hydrogenation route for 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-ylacetic acid intermediates. Cost-effective, scalable process avoiding Grignard reagents.
Patent CN1481354A details a cost-effective nickel-catalyzed hydrogenation route for phenethylamine derivatives, offering significant supply chain advantages over rhodium methods.
Discover the patented HI-reflux synthesis of Tildipirosin intermediates. Achieve high purity and yield while reducing environmental waste for reliable veterinary antibiotic supply chains.
Novel decarboxylation route for FGFR inhibitor intermediate offers high yield and purity. Ideal for cost reduction in API manufacturing and scalable supply chains.
Patent CN1241906C reveals a Rh-doped Raney nickel catalyst for high-selectivity dinitrile conversion, offering significant cost and supply chain advantages for global manufacturers.
Patent CN115975969B reveals advanced transaminase mutants for Sitagliptin. Achieve high conversion and stereoselectivity for reliable pharmaceutical intermediate supply chains.
Patent CN101723902B reveals a stable one-pot route for cilazapril intermediates, offering cost reduction and scalable supply for global pharmaceutical manufacturers.
Novel synthesis of dihydroxy-2-azabicyclo[2.2.1]heptane-3-carboxylic acid derivatives via Mitsunobu rearrangement. Enhanced solubility and bioavailability for API intermediates.
Novel iron-based catalyst process for high-purity 6-aminocapronitrile. Reduces by-products and enhances supply chain reliability for industrial manufacturing.
Patent CN1292777A details a fixed-bed hydrogenation process reducing THA by-products significantly. This enables cost-effective, scalable production of high-purity diamines for global supply chains.